Sign In
Buy AMLX
$13.20
-0.0900 (-0.677%)
At Close: Jun 03, 2026
Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2025 Earnings Call Transcript
02:06pm, Thursday, 06'th Nov 2025
Amylyx Pharmaceuticals, Inc. ( AMLX ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Lindsey Allen Justin Klee - Co-Founder, Co-CEO & Director Camille Bedrosian - Chief Medica
Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results
07:00am, Thursday, 06'th Nov 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today reported financial and business results for the third quarter ended September 3
Philadelphia, Pennsylvania--(Newsfile Corp. - November 4, 2025) - Grabar Law Office is investigating claims on behalf of shareholders of Amylyx
Halper Sadeh LLC Encourages Amylyx Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights
12:20pm, Monday, 27'th Oct 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciar
What Makes Amylyx Pharmaceuticals, Inc. (AMLX) a Strong Momentum Stock: Buy Now?
01:01pm, Friday, 24'th Oct 2025
Does Amylyx Pharmaceuticals, Inc. (AMLX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts See a 29.28% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?
10:56am, Friday, 24'th Oct 2025
The mean of analysts' price targets for Amylyx Pharmaceuticals (AMLX) points to a 29.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement
Has Amylyx Pharmaceuticals (AMLX) Outpaced Other Medical Stocks This Year?
10:40am, Friday, 24'th Oct 2025
Here is how Amylyx Pharmaceuticals, Inc. (AMLX) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm
10:13am, Wednesday, 22'nd Oct 2025
NEW YORK , Oct. 22, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) br
Is AMLX Stock a Solid Choice Right Now?
05:46pm, Thursday, 16'th Oct 2025
Amylyx has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Amylyx allegedly misled investors about Relyvrio's demand and growth, hiding high discontinuation rates and a fading launch surge that hurt its viability.
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm
12:25pm, Monday, 06'th Oct 2025
NEW YORK , Oct. 6, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) bre
Amylyx Pharmaceuticals Announces Pricing of $175 Million Underwritten Public Offering of Common Stock
12:06am, Wednesday, 10'th Sep 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the pricing of an underwritten public offering of 17,500,00
Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock
04:01pm, Tuesday, 09'th Sep 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock.
Amylyx Pharmaceuticals, Inc. (AMLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
09:01pm, Monday, 08'th Sep 2025
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:50 PM EDT Company Participants Justin Klee - Co-Founder, Co-CEO & Director Joshu
Amylyx Pharmaceuticals, Inc. (AMLX) Presents At Citi's Biopharma Back To School Conference Transcript
06:14pm, Tuesday, 02'nd Sep 2025
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX ) Citi's Biopharma Back to School Conference September 2, 2025 1:00 PM EDT Company Participants Joshua Cohen - Co-Founder, Co-CEO & Director Justin Klee - Co-
